Gene · 683
Papers2,228
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,228
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pangenomic analysis reveals plant NAD+ manipulation as an important virulence activity of bacterial pathogen effectors. | Proc Natl Acad Sci U S A | 2023 | 36753463 | PubTator, text mining | PubMed |
| The transient receptor potential melastatin 2: a new therapeutical target for Parkinson's disease? | Neural Regen Res | 2023 | 36751775 | PubTator, text mining | PubMed |
| Linking autism spectrum disorders and parkinsonism: clinical and genetic association. | Ann Clin Transl Neurol | 2023 | 36738194 | PubTator, text mining | PubMed |
| Structural basis underlying the synergism of NADase and SLO during group A Streptococcus infection. | Commun Biol | 2023 | 36721030 | PubTator, text mining | PubMed |
| Dasatinib-induced spleen contraction leads to transient lymphocytosis. | Blood Adv | 2023 | 36583674 | PubTator, text mining | PubMed |
| Pooled evidence from preclinical and clinical studies for stem cell-based therapy in ARDS and COVID-19. | Mol Cell Biochem | 2023 | 36394787 | PubTator, text mining | PubMed |
| Stromal transdifferentiation drives lipomatosis and induces extensive vascular remodeling in the aging human lymph node. | J Pathol | 2023 | 36367235 | PubTator, text mining | PubMed |
| Therapeutic Approaches to Non-Motor Symptoms of Parkinson's Disease: A Current Update on Preclinical Evidence. | Curr Neuropharmacol | 2023 | 36200159 | PubTator, text mining | PubMed |
| Deciphering endothelial heterogeneity in health and disease at single-cell resolution: progress and perspectives. | Cardiovasc Res | 2023 | 35179567 | PubTator, text mining | PubMed |
| The curious case of SARM1: Dr. Jekyll and Mr. Hyde in cell death and immunity? | FEBS J | 2023 | 34710262 | PubTator, text mining | PubMed |
| Systematic characterization of extracellular glycoproteins using mass spectrometry. | Mass Spectrom Rev | 2023 | 34047389 | PubTator, text mining | PubMed |
| Single-cell profiling reveals distinct subsets of CD14+ monocytes drive blood immune signatures of active tuberculosis. | Front Immunol | 2022 | 36713384 | PubTator, text mining | PubMed |
Transcriptomic Analysis of the Effect of Metformin against Cisplatin-Induced Ototoxicity: A Potential Mechanism of Metformin-Mediated Inhibition of Thioredoxin-Interacting Protein (Txnip) Gene Expression. | Curr Issues Mol Biol | 2022 | 36661507 | PubTator, text mining | PubMed |
| Neutrophil dynamics and inflammaging in acute ischemic stroke: A transcriptomic review. | Front Aging Neurosci | 2022 | 36620775 | PubTator, text mining | PubMed |
| Photocatalytic Performance and Kinetic Studies of a Wood Surface Loaded with Bi2O3-Doped Silicon-Titanium Composite Film. | Polymers (Basel) | 2022 | 36616374 | PubTator, text mining | PubMed |
| Roles of NAD+ in Acute and Chronic Kidney Diseases. | Int J Mol Sci | 2022 | 36613582 | PubTator, text mining | PubMed |
| Prediction of Cervical Cancer Outcome by Identifying and Validating a NAD+ Metabolism-Derived Gene Signature. | J Pers Med | 2022 | 36556252 | PubTator, text mining | PubMed |
| How Well Do Rodent Models of Parkinson's Disease Recapitulate Early Non-Motor Phenotypes? A Systematic Review. | Biomedicines | 2022 | 36551782 | PubTator, text mining | PubMed |
| Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors. | J Transl Med | 2022 | 36528667 | PubTator, text mining | PubMed |
| Pathogenesis of α-Synuclein in Parkinson's Disease: From a Neuron-Glia Crosstalk Perspective. | Int J Mol Sci | 2022 | 36499080 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/683/papers?page=8